Home

Inżynierowie stos różnica polo kinase Petent Szkodliwy Monetarny

Polo-like kinase in trypanosomes: an odd member out of the Polo family |  Open Biology
Polo-like kinase in trypanosomes: an odd member out of the Polo family | Open Biology

Putting a bit into the polo-box domain of polo-like kinase 1 | SpringerLink
Putting a bit into the polo-box domain of polo-like kinase 1 | SpringerLink

Genes | Free Full-Text | The Mitotic Cancer Target Polo-Like Kinase 1:  Oncogene or Tumor Suppressor?
Genes | Free Full-Text | The Mitotic Cancer Target Polo-Like Kinase 1: Oncogene or Tumor Suppressor?

Mitotic Roles of Polo Like Kinase
Mitotic Roles of Polo Like Kinase

Dual targeting of Polo-like kinase 1 and baculoviral inhibitor of apoptosis  repeat-containing 5 in TP53-mutated hepatocellular carcinoma
Dual targeting of Polo-like kinase 1 and baculoviral inhibitor of apoptosis repeat-containing 5 in TP53-mutated hepatocellular carcinoma

Polo-like Kinase 1 Inhibitors and Their Potential Role in Anticancer  Therapy, with a Focus on NSCLC | Clinical Cancer Research
Polo-like Kinase 1 Inhibitors and Their Potential Role in Anticancer Therapy, with a Focus on NSCLC | Clinical Cancer Research

QIAGEN - GeneGlobe Pathways - Mitotic Roles of Polo Like Kinases
QIAGEN - GeneGlobe Pathways - Mitotic Roles of Polo Like Kinases

Cancers | Free Full-Text | The Emerging Role of Polo-Like Kinase 1 in  Epithelial-Mesenchymal Transition and Tumor Metastasis | HTML
Cancers | Free Full-Text | The Emerging Role of Polo-Like Kinase 1 in Epithelial-Mesenchymal Transition and Tumor Metastasis | HTML

Autoinhibition and relief mechanism for Polo-like kinase 4 | PNAS
Autoinhibition and relief mechanism for Polo-like kinase 4 | PNAS

Figure 2 from Polo-like kinase (PLK) inhibitors in preclinical and early  clinical development in oncology. | Semantic Scholar
Figure 2 from Polo-like kinase (PLK) inhibitors in preclinical and early clinical development in oncology. | Semantic Scholar

The Role of Polo-like Kinase 1 in Carcinogenesis: Cause or Consequence? |  Cancer Research
The Role of Polo-like Kinase 1 in Carcinogenesis: Cause or Consequence? | Cancer Research

A unified view of spatio-temporal control of mitotic entry: Polo kinase as  the key | Open Biology
A unified view of spatio-temporal control of mitotic entry: Polo kinase as the key | Open Biology

Polo-like Kinase 1 Inhibitors and Their Potential Role in Anticancer  Therapy, with a Focus on NSCLC | Clinical Cancer Research
Polo-like Kinase 1 Inhibitors and Their Potential Role in Anticancer Therapy, with a Focus on NSCLC | Clinical Cancer Research

Discovery and development of the Polo-like kinase inhibitor volasertib in  cancer therapy | Leukemia
Discovery and development of the Polo-like kinase inhibitor volasertib in cancer therapy | Leukemia

Polo-like kinases and the orchestration of cell division | Nature Reviews  Molecular Cell Biology
Polo-like kinases and the orchestration of cell division | Nature Reviews Molecular Cell Biology

Targeting Polo-like Kinase in Cancer Therapy | Clinical Cancer Research
Targeting Polo-like Kinase in Cancer Therapy | Clinical Cancer Research

Targeting Polo-Like Kinases: A Promising Therapeutic Approach for Cancer  Treatment - ScienceDirect
Targeting Polo-Like Kinases: A Promising Therapeutic Approach for Cancer Treatment - ScienceDirect

Polo Like Kinase-enzyme
Polo Like Kinase-enzyme

Polo-like kinases: conservation and divergence in their functions and  regulation | Nature Reviews Molecular Cell Biology
Polo-like kinases: conservation and divergence in their functions and regulation | Nature Reviews Molecular Cell Biology

Cancers | Free Full-Text | The CINs of Polo-Like Kinase 1 in Cancer
Cancers | Free Full-Text | The CINs of Polo-Like Kinase 1 in Cancer

Understanding the Polo Kinase machine | Oncogene
Understanding the Polo Kinase machine | Oncogene

Aurora B activity is required for the activation of Polo kinase at the... |  Download Scientific Diagram
Aurora B activity is required for the activation of Polo kinase at the... | Download Scientific Diagram

Proline-Rich Motifs Control G2-CDK Target Phosphorylation and Priming an  Anchoring Protein for Polo Kinase Localization. - Cell Rep. - X-MOL
Proline-Rich Motifs Control G2-CDK Target Phosphorylation and Priming an Anchoring Protein for Polo Kinase Localization. - Cell Rep. - X-MOL

Functional Dynamics of Polo-Like Kinase 1 at the Centrosome | Molecular and  Cellular Biology
Functional Dynamics of Polo-Like Kinase 1 at the Centrosome | Molecular and Cellular Biology

Capturing Polo Kinase | Science
Capturing Polo Kinase | Science

Dual targeting of Polo-like kinase 1 and baculoviral inhibitor of apoptosis  repeat-containing 5 in TP53-mutated hepatocellular carcinoma
Dual targeting of Polo-like kinase 1 and baculoviral inhibitor of apoptosis repeat-containing 5 in TP53-mutated hepatocellular carcinoma

Polo-like Kinase 1 Licenses CENP-A Deposition at Centromeres - ScienceDirect
Polo-like Kinase 1 Licenses CENP-A Deposition at Centromeres - ScienceDirect

Frontiers | A Perspective on Polo-Like Kinase-1 Inhibition for the  Treatment of Rhabdomyosarcomas | Oncology
Frontiers | A Perspective on Polo-Like Kinase-1 Inhibition for the Treatment of Rhabdomyosarcomas | Oncology